Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Recruiting 1

Sponsor Class

NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1Lymphoid 1Gynecologic 1Genitourinary 1Gastrointestinal 1Dermatologic 1CNS 1

Conditions

Breast Neoplasms 5Osteoporosis 4Wilms Tumor 1Unspecified Childhood Solid Tumor, Protocol Specific 1Sarcoma, Ewing 1Ovarian Neoplasms 1Osteosarcoma 1Neuroblastoma 1Melanoma 1Lymphoma, Non-Hodgkin 1Hepatoblastoma 1Endometrial Neoplasms 1Desmoid Tumors 1Colorectal Neoplasms 1Carcinoma, Hepatocellular 1

Interventions

Ifosfamide 5Doxorubicin 4Specimen Handling 3Methotrexate 3Etoposide 3Cisplatin 3Sorafenib 2Granulocyte Colony-Stimulating Factor 2Filgrastim 2sodium thiosulfate 1sargramostim 1pepinemab 1peginterferon alfa-2b 1mifamurtide 1merphos 1lorukafusp alfa 1irinotecan sucrosofate 1imetelstat 1etoposide phosphate 1Zoledronic Acid 1X-Rays 1Thrombopoietin 1Thoracotomy 1Thoracostomy 1Thoracoscopy 1Surgical Procedures, Operative 1Reverse Transcriptase Polymerase Chain Reaction 1Restraint, Physical 1Razoxane 1Radiotherapy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
NETWORK × Osteosarcoma × Absorptiometry, Photon × Clear all
NCT04851119 2026-05-05

Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors

Children's Oncology Group

Phase 1/2 Recruiting
147 enrolled
CNSDermatologicGastrointestinalGenitourinaryGynecologicLymphoidSarcoma

Carcinoma, Hepatocellular, Lymphoma, Non-Hodgkin, Melanoma, Wilms Tumor, Neuroblastoma, Ovarian Neoplasms, Sarcoma, Ewing, Osteosarcoma, Colorectal Neoplasms, Endometrial Neoplasms, Hepatoblastoma, Desmoid Tumors

Data powered by HemOnc (CC BY 4.0) Colophon âš¡